The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
Open accessAbstract
High-density lipoproteins (HDL) are endogenous nanoparticles involved in the transport and metabolism of cholesterol, phospholipids, and triglycerides. HDL is well-known as the “good” cholesterol because it not only removes excess cholesterol from atherosclerotic plaques but also has anti-inflammatory and antioxidative properties, which protect the cardiovascular system. Circulating HDL also transports endogenous proteins, vitamins, hormones, and microRNA to various organs. Compared with other synthetic nanocarriers, such as liposomes, micelles, and inorganic and polymeric nanoparticles, HDL has unique features that allow them to deliver cargo to specific targets more efficiently. These attributes include their ultrasmall size (8–12 nm in diameter), high tolerability in humans (up to 8 g of protein per infusion), long circulating half-life (12–24 h), and intrinsic targeting properties to different recipient cells. Various recombinant ApoA proteins and ApoA mimetic peptides have been recently developed for the preparation of reconstituted HDL that exhibits properties similar to those of endogenous HDL and has a potential for industrial scale-up. In this review, we will summarize (a) clinical pharmacokinetics and safety of reconstituted HDL products, (b) comparison of HDL with inorganic and other organic nanoparticles, (c) the rationale for using HDL as drug delivery vehicles for important therapeutic indications, (d) the current state-of-the-art in HDL production, and (e) HDL-based drug delivery strategies for small molecules, peptides/proteins, nucleic acids, and imaging agents targeted to various organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2210 · Cited by 2,741
Atherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., & Shiekhattar, R. (2005) · Nature · doi:10.1038/nature03868 · Cited by 2,100
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Khlebtsov, N., & Dykman, L. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00018c · Cited by 1,584
Inferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,466
Maier-Hauff, K., Ulrich, F., Nestler, D., Niehoff, H., Wust, P., Thiesen, B., Orawa, H., Budach, V., & Jordan, A. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0389-0 · Cited by 1,429
Allen, T. M., Hansen, C., Martin, F., Redemann, C., & Yau-Young, A. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,391
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
ELSAYED, I., HUANG, X., & ELSAYED, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.035 · Cited by 1,354
HATCH, F. T., & LEES, R. S. (1968) · Advances in Lipid Research · doi:10.1016/b978-1-4831-9942-9.50008-5 · Cited by 1,234
Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., & Zamore, P. D. (2005) · Cell · doi:10.1016/j.cell.2005.08.044 · Cited by 1,211
(1966) · Index to Reviews, Symposia Volumes and Monographs in Organic Chemistry · doi:10.1016/b978-0-08-012210-6.50017-x · Cited by 1,190
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold Nanorod Antennas
von Maltzahn, G., Park, J.-H., Agrawal, A., Bandaru, N. K., Das, S. K., Sailor, M. J., & Bhatia, S. N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4242 · Cited by 1,051
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Protein release from gelatin matrices
Tabata, Y. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00125-7 · Cited by 839
The safety of statins in clinical practice
Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833
Wang, F., Wang, Y.-C., Dou, S., Xiong, M.-H., Sun, T.-M., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn200007z · Cited by 813
Multifunctional Gold Nanoparticle−Peptide Complexes for Nuclear Targeting
Tkachenko, A. G., Xie, H., Coleman, D., Glomm, W., Ryan, J., Anderson, M. F., Franzen, S., & Feldheim, D. L. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0296935 · Cited by 794
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Mishra, S., Webster, P., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 730
Tardif, J.-C. (2007) · JAMA · doi:10.1001/jama.297.15.jpc70004 · Cited by 726
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Phillips, E., Penate-Medina, O., Zanzonico, P. B., Carvajal, R. D., Mohan, P., Ye, Y., Humm, J., Gönen, M., Kalaigian, H., Schöder, H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009524 · Cited by 712
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
Assessment of the In Vivo Toxicity of Gold Nanoparticles
Chen, Y.-S., Hung, Y.-C., Liau, I., & Huang, G. S. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9334-6 · Cited by 695
Self-citationXie, J., Xu, C., Kohler, N., Hou, Y., & Sun, S. (2007) · Advanced Materials · doi:10.1002/adma.200701975 · Cited by 686
Central tolerance: learning self-control in the thymus
Hogquist, K. A., Baldwin, T. A., & Jameson, S. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1707 · Cited by 659
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Navab, M., Reddy, S. T., Van Lenten, B. J., & Fogelman, A. M. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.222 · Cited by 656
Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles
Cho, W.-S., Cho, M., Jeong, J., Choi, M., Cho, H.-Y., Han, B. S., Kim, S. H., Kim, H. O., Lim, Y. T., Chung, B. H., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.12.023 · Cited by 651
Hatakeyama, H., Akita, H., & Harashima, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.001 · Cited by 645
Frank-Kamenetsky, M., Grefhorst, A., Anderson, N. N., Racie, T. S., Bramlage, B., Akinc, A., Butler, D., Charisse, K., Dorkin, R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 642
Gene Regulation with Polyvalent siRNA−Nanoparticle Conjugates
Giljohann, D. A., Seferos, D. S., Prigodich, A. E., Patel, P. C., & Mirkin, C. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808719p · Cited by 637
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 634
Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 603
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 599
HDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans
Kennedy, S., Wang, D., & Ruvkun, G. (2004) · Nature · doi:10.1038/nature02302 · Cited by 592
Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice
Lasagna-Reeves, C., Gonzalez-Romero, D., Barria, M. A., Olmedo, I., Clos, A., Sadagopa Ramanujam, V. M., Urayama, A., Vergara, L., Kogan, M. J., & Soto, C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.046 · Cited by 584
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
Heyes, J., Palmer, L., Bremner, K., & MacLachlan, I. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.014 · Cited by 572
Polymeric micelles drug delivery system in oncology
Gong, J., Chen, M., Zheng, Y., Wang, S., & Wang, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.012 · Cited by 570
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis
Tall, A. R., Yvan-Charvet, L., Terasaka, N., Pagler, T., & Wang, N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.001 · Cited by 540
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 528
Biochemistry of Lipids, Lipoproteins and Membranes
(2008) · Elsevier eBooks · doi:10.1016/b978-0-444-53219-0.x5001-6 · Cited by 513
A Review of Clinical Translation of Inorganic Nanoparticles
Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509
Host defense peptides as new weapons in cancer treatment
Papo, N., & Shai, Y. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4560-2 · Cited by 501
Aguilar, J. C., & Rodríguez, E. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.111 · Cited by 494
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Ishida, T., & Kiwada, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.005 · Cited by 490
Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
Li, S.-D., & Huang, L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.022 · Cited by 486
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Gullotti, E., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900090z · Cited by 473
Mechanisms maintaining peripheral tolerance
Mueller, D. L. (2010) · Nature Immunology · doi:10.1038/ni.1817 · Cited by 461
Chemical Modification of siRNAs for In Vivo Use
Behlke, M. A. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0164 · Cited by 454
Duivenvoorden, R., Tang, J., Cormode, D. P., Mieszawska, A. J., Izquierdo-Garcia, D., Ozcan, C., Otten, M. J., Zaidi, N., Lobatto, M. E., van Rijs, S. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4065 · Cited by 442
High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men
Spieker, L. E., Sudano, I., Hürlimann, D., Lerch, P. G., Lang, M. G., Binggeli, C., Corti, R., Ruschitzka, F., Lüscher, T. F., & Noll, G. (2002) · Circulation · doi:10.1161/01.cir.0000013424.28206.8f · Cited by 438
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
Tabet, F., Vickers, K. C., Cuesta Torres, L. F., Wiese, C. B., Shoucri, B. M., Lambert, G., Catherinet, C., Prado-Lourenco, L., Levin, M. G., Thacker, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4292 · Cited by 428
Wang, X., Ishida, T., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.010 · Cited by 421
Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
Apolipoprotein-mediated pathways of lipid antigen presentation
Elzen, P. V. D., Garg, S., León, L., Brigl, M., Leadbetter, E. A., Gumperz, J. E., Dascher, C. C., Cheng, T.-Y., Sacks, F. M., Illarionov, P. A., et al. (2005) · Nature · doi:10.1038/nature04001 · Cited by 380
HDL-targeted therapies: progress, failures and future
Kingwell, B. A., Chapman, M. J., Kontush, A., & Miller, N. E. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4279 · Cited by 354
Protein-lipid relationships in human plasma
Russ, E. M., Eder, H. A., & Barr, D. P. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90182-9 · Cited by 351
Shah, A. S., Tan, L., Long, J. L., & Davidson, W. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r035725 · Cited by 351
Lipoprotein-Inspired Nanoparticles for Cancer Theranostics
Ng, K. K., Lovell, J. F., & Zheng, G. (2011) · Accounts of Chemical Research · doi:10.1021/ar200017e · Cited by 330
Camptothecin and taxol: Discovery to clinic
Wall, M. E. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<299::aid-med2>3.0.co;2-o · Cited by 330
Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform
Cormode, D. P., Skajaa, T., van Schooneveld, M. M., Koole, R., Jarzyna, P., Lobatto, M. E., Calcagno, C., Barazza, A., Gordon, R. E., Zanzonico, P., et al. (2008) · Nano Letters · doi:10.1021/nl801958b · Cited by 328
Wilson, J. T., Keller, S., Manganiello, M. J., Cheng, C., Lee, C.-C., Opara, C., Convertine, A., & Stayton, P. S. (2013) · ACS Nano · doi:10.1021/nn305466z · Cited by 317
Biomaterials for Nanoparticle Vaccine Delivery Systems
Sahdev, P., Ochyl, L. J., & Moon, J. J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1419-y · Cited by 310
Self-citationVirus-mediated gene delivery for human gene therapy
Giacca, M., & Zacchigna, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.008 · Cited by 302
Recombinant HDL-Like Nanoparticles: A Specific Contrast Agent for MRI of Atherosclerotic Plaques
Frias, J. C., Williams, K. J., Fisher, E. A., & Fayad, Z. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja044911a · Cited by 299
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Hamdy, S., Haddadi, A., Hung, R. W., & Lavasanifar, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.021 · Cited by 298
Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
Kontush, A., & Chapman, M. J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833bcdc1 · Cited by 293
EDER, P. S., DeVINE, R. J., DAGLE, J. M., & WALDER, J. A. (1991) · Antisense Research and Development · doi:10.1089/ard.1991.1.141 · Cited by 293
Bisoendial, R. J., Hovingh, G. K., Levels, J. H. M., Lerch, P. G., Andresen, I., Hayden, M. R., Kastelein, J. J. P., & Stroes, E. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000070934.69310.1a · Cited by 288
Shaw, J. A., Bobik, A., Murphy, A., Kanellakis, P., Blombery, P., Mukhamedova, N., Woollard, K., Lyon, S., Sviridov, D., & Dart, A. M. (2008) · Circulation Research · doi:10.1161/circresaha.108.182063 · Cited by 275
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Meade, B. R., & Dowdy, S. F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.004 · Cited by 274
Bellin, M. F., Roy, C., Kinkel, K., Thoumas, D., Zaim, S., Vanel, D., Tuchmann, C., Richard, F., Jacqmin, D., Delcourt, A., et al. (1998) · Radiology · doi:10.1148/radiology.207.3.9609907 · Cited by 261
Lipid-Based Nanoparticles for siRNA Delivery in Cancer Therapy: Paradigms and Challenges
Gomes-da-Silva, L. C., Fonseca, N. A., Moura, V., Pedroso de Lima, M. C., Simões, S., & Moreira, J. N. (2012) · Accounts of Chemical Research · doi:10.1021/ar300048p · Cited by 254
Hamad, I., Hunter, A. C., Szebeni, J., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.276 · Cited by 253
Tardif, J.-C., Ballantyne, C. M., Barter, P., Dasseux, J.-L., Fayad, Z. A., Guertin, M.-C., Kastelein, J. J. P., Keyserling, C., Klepp, H., Koenig, W., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu171 · Cited by 251
What are lipoproteins doing in the brain?
Wang, H., & Eckel, R. H. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.10.003 · Cited by 234
Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth
Siperstein, M. D. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34419-9 · Cited by 234
Eriksson, M., Carlson, L. A., Miettinen, T. A., & Angelin, B. (1999) · Circulation · doi:10.1161/01.cir.100.6.594 · Cited by 228
HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation
Blaho, V. A., Galvani, S., Engelbrecht, E., Liu, C., Swendeman, S. L., Kono, M., Proia, R. L., Steinman, L., Han, M. H., & Hla, T. (2015) · Nature · doi:10.1038/nature14462 · Cited by 227
Evaluation of the Toxicity of Intravenous Delivery of Auroshell Particles (Gold–Silica Nanoshells)
Gad, S. C., Sharp, K. L., Montgomery, C., Payne, J. D., & Goodrich, G. P. (2012) · International Journal of Toxicology · doi:10.1177/1091581812465969 · Cited by 227
Feasibility Study of Particle-Assisted Laser Ablation of Brain Tumors in Orthotopic Canine Model
Schwartz, J. A., Shetty, A. M., Price, R. E., Stafford, R. J., Wang, J. C., Uthamanthil, R. K., Pham, K., McNichols, R. J., Coleman, C. L., & Payne, J. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2535 · Cited by 222
Shahzad, M. M. K., Mangala, L. S., Han, H. D., Lu, C., Bottsford-Miller, J., Nishimura, M., Mora, E. M., Lee, J.-W., Stone, R. L., Pecot, C. V., et al. (2011) · Neoplasia · doi:10.1593/neo.101372 · Cited by 221
Song, Q., Huang, M., Yao, L., Wang, X., Gu, X., Chen, J., Chen, J., Huang, J., Hu, Q., Kang, T., et al. (2014) · ACS Nano · doi:10.1021/nn4058215 · Cited by 219
Xu, Z., Ramishetti, S., Tseng, Y.-C., Guo, S., Wang, Y., & Huang, L. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.021 · Cited by 219
Nanoparticles Escaping RES and Endosome: Challenges for siRNA Delivery for Cancer Therapy
Guo, S., & Huang, L. (2011) · Journal of Nanomaterials · doi:10.1155/2011/742895 · Cited by 216
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
Rensen, P. C. N., de Vrueh, R. L. A., Kuiper, J., Bijsterbosch, M. K., Biessen, E. A. L., & van Berkel, T. J. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00109-0 · Cited by 215
Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides
Mutwiri, G. K., Nichani, A. K., Babiuk, S., & Babiuk, L. A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.022 · Cited by 208
Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway
Liu, S., Yu, M., He, Y., Xiao, L., Wang, F., Song, C., Sun, S., Ling, C., & Xu, Z. (2008) · Hepatology · doi:10.1002/hep.22240 · Cited by 206
Polymeric micelles as drug carriers: their lights and shadows
Yokoyama, M. (2014) · Journal of Drug Targeting · doi:10.3109/1061186x.2014.934688 · Cited by 205
Patel, S., Drew, B. G., Nakhla, S., Duffy, S. J., Murphy, A. J., Barter, P. J., Rye, K.-A., Chin-Dusting, J., Hoang, A., Sviridov, D., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.008 · Cited by 203
Calkin, A. C., Drew, B. G., Ono, A., Duffy, S. J., Gordon, M. V., Schoenwaelder, S. M., Sviridov, D., Cooper, M. E., Kingwell, B. A., & Jackson, S. P. (2009) · Circulation · doi:10.1161/circulationaha.109.870709 · Cited by 200
Polymers in Small-Interfering RNA Delivery
Singha, K., Namgung, R., & Kim, W. J. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0293 · Cited by 198
Yuba, E., Harada, A., Sakanishi, Y., Watarai, S., & Kono, K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.031 · Cited by 196
Targeting tumor antigens to dendritic cells using particulate carriers
Joshi, M. D., Unger, W. J., Storm, G., van Kooyk, Y., & Mastrobattista, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.010 · Cited by 196
Phase I clinical evaluation of a new iron oxide MR contrast agent
McLachlan, S. J., Morris, M. R., Lucas, M. A., Fisco, R. A., Eakins, M. N., Fowler, D. R., Scheetz, R. B., & Olukotun, A. Y. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040313 · Cited by 194
Emerging role of high density lipoproteins as a player in the immune system
Norata, G. D., Pirillo, A., Ammirati, E., & Catapano, A. L. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.045 · Cited by 192
Laboratory Assessment of HDL Heterogeneity and Function
Movva, R., & Rader, D. J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101923 · Cited by 188
Statins as Potent Antiinflammatory Drugs
Lefer, D. J. (2002) · Circulation · doi:10.1161/01.cir.0000033635.42612.88 · Cited by 182
Hahn, P. F., Stark, D. D., Lewis, J. M., Saini, S., Elizondo, G., Weissleder, R., Fretz, C. J., & Ferrucci, J. T. (1990) · Radiology · doi:10.1148/radiology.175.3.2343116 · Cited by 181
Sattler, K., & Levkau, B. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp070 · Cited by 174
Drug targeting to the diseased liver
Poelstra, K., Prakash, J., & Beljaars, L. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.011 · Cited by 172
A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics
Cui, L., Lin, Q., Jin, C. S., Jiang, W., Huang, H., Ding, L., Muhanna, N., Irish, J. C., Wang, F., Chen, J., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b01077 · Cited by 172
Leon, C. G., Locke, J. A., Adomat, H. H., Etinger, S. L., Twiddy, A. L., Neumann, R. D., Nelson, C. C., Guns, E. S., & Wasan, K. M. (2010) · The Prostate · doi:10.1002/pros.21072 · Cited by 168
HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages
Sanchez-Gaytan, B. L., Fay, F., Lobatto, M. E., Tang, J., Ouimet, M., Kim, Y., van der Staay, S. E. M., van Rijs, S. M., Priem, B., Zhang, L., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500517k · Cited by 168
Innovative strategies for co-delivering antigens and CpG oligonucleotides
Krishnamachari, Y., & Salem, A. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.013 · Cited by 160
HDL: The Metabolism, Function, and Therapeutic Importance
Wang, M., & Briggs, M. R. (2004) · Chemical Reviews · doi:10.1021/cr020466v · Cited by 158
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhang, Z., Cao, W., Jin, H., Lovell, J. F., Yang, M., Ding, L., Chen, J., Corbin, I., Luo, Q., & Zheng, G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903112 · Cited by 158
Koole, R., van Schooneveld, M. M., Hilhorst, J., Castermans, K., Cormode, D. P., Strijkers, G. J., Donegá, C. D. M., Vanmaekelbergh, D. A. M., Griffioen, A. W., Nicolay, K., et al. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800368x · Cited by 158
Loss of Collagen XVIII Enhances Neovascularization and Vascular Permeability in Atherosclerosis
Moulton, K. S., Olsen, B. R., Sonn, S., Fukai, N., Zurakowski, D., & Zeng, X. (2004) · Circulation · doi:10.1161/01.cir.0000140720.79015.3c · Cited by 157
HDL in sepsis – risk factor and therapeutic approach
Morin, E. E., Guo, L., Schwendeman, A. A., & Li, X. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00244 · Cited by 154
Self-citationMolino, N. M., Anderson, A. K. L., Nelson, E. L., & Wang, S. (2013) · ACS Nano · doi:10.1021/nn403085w · Cited by 153
Safety of Ferumoxytol in Patients With Anemia and CKD
Singh, A. K., Patel, T. V., Hertel, J., Bernardo, M. V., Kausz, A., & Brenner, L. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.08.001 · Cited by 147
HDL‐Mimicking Peptide–Lipid Nanoparticles with Improved Tumor Targeting
Zhang, Z., Chen, J., Ding, L., Jin, H., Lovell, J. F., Corbin, I. R., Cao, W., Lo, P., Yang, M., Tsao, M., et al. (2009) · Small · doi:10.1002/smll.200901515 · Cited by 147
Nanjee, M. N., Doran, J. E., Lerch, P. G., & Miller, N. E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.979 · Cited by 145
Curcumin nanodisks: formulation and characterization
Ghosh, M., Singh, A. T. K., Xu, W., Sulchek, T., Gordon, L. I., & Ryan, R. O. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.08.002 · Cited by 143
Current methods for the synthesis of homogeneous antibody–drug conjugates
Sochaj, A. M., Świderska, K. W., & Otlewski, J. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.001 · Cited by 142
Kim, S. K., Foote, M. B., & Huang, L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.010 · Cited by 136
Huang, C., Jin, H., Qian, Y., Qi, S., Luo, H., Luo, Q., & Zhang, Z. (2013) · ACS Nano · doi:10.1021/nn400683s · Cited by 131
Lerch, P. G., Förtsch, V., Hodler, G., & Bolli, R. (1996) · Vox Sanguinis · doi:10.1046/j.1423-0410.1996.7130155.x · Cited by 130
Huang, M., Hu, M., Song, Q., Song, H., Huang, J., Gu, X., Wang, X., Chen, J., Kang, T., Feng, X., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03124 · Cited by 127
Strategies for In Vivo Delivery of siRNAs: Recent Progress
Higuchi, Y., Kawakami, S., & Hashida, M. (2010) · BioDrugs · doi:10.2165/11534450-000000000-00000 · Cited by 127
Biomimetic High Density Lipoprotein Nanoparticles For Nucleic Acid Delivery
McMahon, K. M., Mutharasan, R. K., Tripathy, S., Veliceasa, D., Bobeica, M., Shumaker, D. K., Luthi, A. J., Helfand, B. T., Ardehali, H., Mirkin, C. A., et al. (2011) · Nano Letters · doi:10.1021/nl1041947 · Cited by 125
Kim, Y., Fay, F., Cormode, D. P., Sánchez-Gaytán, B. L., Tang, J., Hennessy, E. J., Ma, M., Moore, K. J., Farokhzad, O. C., Fisher, E. A. A., et al. (2013) · ACS Nano · doi:10.1021/nn4039063 · Cited by 125
Templated Spherical High Density Lipoprotein Nanoparticles
Thaxton, C. S., Daniel, W. L., Giljohann, D. A., Thomas, A. D., & Mirkin, C. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808856z · Cited by 122
Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery
Damiano, M. G., Mutharasan, R. K., Tripathy, S., McMahon, K. M., & Thaxton, C. S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.013 · Cited by 121
High Density Lipoprotein-associated Sphingosine 1-Phosphate Promotes Endothelial Barrier Function
Argraves, K. M., Gazzolo, P. J., Groh, E. M., Wilkerson, B. A., Matsuura, B. S., Twal, W. O., Hammad, S. M., & Argraves, W. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801214200 · Cited by 121
Gille, A., Easton, R., D’Andrea, D. M., Wright, S. D., & Shear, C. L. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303720 · Cited by 119
Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel
McConathy, W. J., Nair, M. P., Paranjape, S., Mooberry, L. K., & Lacko, A. G. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282f1da86 · Cited by 119
Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier
Mooberry, L. K., Nair, M. P., Paranjape, S., McConathy, W. J., & Lacko, A. G. (2009) · Journal of drug targeting · doi:10.3109/10611860903156419 · Cited by 117
Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B
Oda, M. N., Hargreaves, P. L., Beckstead, J. A., Redmond, K. A., van Antwerpen, R., & Ryan, R. O. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d500033-jlr200 · Cited by 113
Chen, W., Jarzyna, P. A., van Tilborg, G. A. F., Nguyen, A. V., Cormode, D. P., Klink, A., Griffioen, A. W., Randolph, G. J., Fisher, E. A. A., Mulder, W. J. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139865 · Cited by 112
Reconstituted Lipoprotein: A Versatile Class of Biologically-Inspired Nanostructures
Bricarello, D. A., Smilowitz, J. T., Zivkovic, A. M., German, J. B., & Parikh, A. N. (2010) · ACS Nano · doi:10.1021/nn103098m · Cited by 112
Cormode, D. P., Briley-Saebo, K. C., Mulder, W. J. M., Aguinaldo, J. G. S., Barazza, A., Ma, Y., Fisher, E. A. A., & Fayad, Z. A. (2008) · Small · doi:10.1002/smll.200701285 · Cited by 109
Schwendeman, A. A., Sviridov, D. O., Yuan, W., Guo, Y., Morin, E. E., Yuan, Y., Stonik, J. A., Freeman, L. A., Ossoli, A., Thacker, S. G., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m060285 · Cited by 106
Self-citationVitols, S., Norgren, S., Juliusson, G., Tatidis, L., & Luthman, H. (1994) · Blood · doi:10.1182/blood.v84.8.2689.2689 · Cited by 105
Advances in the synthesis and application of nanoparticles for drug delivery
Park, W., & Na, K. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1325 · Cited by 103
Fischer, N. O., Rasley, A., Corzett, M., Hwang, M. H., Hoeprich, P. D., & Blanchette, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3063293 · Cited by 96
Zhang, W., He, H., Liu, J., Wang, J., Zhang, S., Zhang, S., & Wu, Z. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.058 · Cited by 92
Wang, H., Xiong, M., Wang, Y., Zhu, J., & Wang, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.017 · Cited by 90
Pussinen, P. J., Karten, B., Wintersperger, A., Reicher, H., McLean, M. P., Malle, E., & Sattler, W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490559 · Cited by 90
Efficient Cytosolic Delivery of siRNA Using HDL‐Mimicking Nanoparticles
Yang, M., Jin, H., Chen, J., Ding, L., Ng, K. K., Lin, Q., Lovell, J. F., Zhang, Z., & Zheng, G. (2011) · Small · doi:10.1002/smll.201001589 · Cited by 89
A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I
Easton, R., Gille, A., D’Andrea, D. M., Davis, R., Wright, S. D., & Shear, C. L. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.194 · Cited by 88
Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal
Navab, M., Anantharamaiah, G. M., Reddy, S. T., Lenten, B. J. V., Datta, G., Garber, D. W., & Fogelman, A. M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200412000-00004 · Cited by 81
High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm
Tuteja, S., & Rader, D. J. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.79 · Cited by 77
Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles
Nakayama, T., Butler, J. S., Sehgal, A., Severgnini, M., Racie, T., Sharman, J., Ding, F., Shulga‐Morskaya, S., Brodsky, J., Tchangov, L., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.33 · Cited by 76
Reconstituted HDL for the acute treatment of acute coronary syndrome
Krause, B. R., & Remaley, A. T. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000020 · Cited by 75
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients
Spinowitz, B., Schwenk, M. H., Jacobs, P. M., Bolton, W. K., Kaplan, M. R., Charytan, C., & Galler, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00598.x · Cited by 74
Luthi, A. J., Zhang, H., Kim, D., Giljohann, D. A., Mirkin, C. A., & Thaxton, C. S. (2011) · ACS Nano · doi:10.1021/nn2035457 · Cited by 73
Bartolo, B. A. D., Nicholls, S. J., Bao, S., Rye, K.-A., Heather, A. K., Barter, P. J., & Bursill, C. A. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.001 · Cited by 73
Kuwahara, H., Nishina, K., Yoshida, K., Nishina, T., Yamamoto, M., Saito, Y., Piao, W., Yoshida, M., Mizusawa, H., & Yokota, T. (2011) · Molecular Therapy · doi:10.1038/mt.2011.186 · Cited by 71
Skajaa, T., Cormode, D. P., Jarzyna, P. A., Delshad, A., Blachford, C., Barazza, A., Fisher, E. A., Gordon, R. E., Fayad, Z. A., & Mulder, W. J. M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.078 · Cited by 69
Hovingh, G. K., Smits, L. P., Stefanutti, C., Soran, H., Kwok, S., Graaf, J. D., Gaudet, D., Keyserling, C., Klepp, H., Frick, J. E., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.01.008 · Cited by 69
Lipoprotein Nanoplatform for Targeted Delivery of Diagnostic and Therapeutic Agents
Glickson, J. D., Lund‐Katz, S., Zhou, R., Choi, H., Chen, I., Li, H., Corbin, I. R., Popov, A. V., Cao, W., Song, L., et al. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-85998-9_35 · Cited by 65
Ichikawa, K., Takeuchi, Y., Yonezawa, S., Hikita, T., Kurohane, K., Namba, Y., & Oku, N. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.10.001 · Cited by 65
van Oostrom, O., Nieuwdorp, M., Westerweel, P. E., Hoefer, I. E., Basser, R., Stroes, E. S. G., & Verhaar, M. C. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.143875 · Cited by 60
Evaluation au laboratoire de l’hétérogénéité et des fonctions des HDL (version française)
Movva, R., & Rader, D. J. (2008) · Annales de biologie clinique · doi:10.1684/abc.2008.0284 · Cited by 59
Imaging the Cytosolic Drug Delivery Mechanism of HDL-Like Nanoparticles
Lin, Q., Chen, J., Ng, K. K., Cao, W., Zhang, Z., & Zheng, G. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1046-z · Cited by 58
Nicoll, A., Colledge, D., Toole, J. J., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3130 · Cited by 56
Curcumin nanodisk-induced apoptosis in mantle cell lymphoma
Singh, A. T. K., Ghosh, M., Forte, T. M., Ryan, R. O., & Gordon, L. I. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.584253 · Cited by 53
Low-density lipoprotein metabolism in mice with soft tissue tumours
Hynds, S. A., Welsh, J., Stewart, J. M., Jack, A., Soukop, M., McArdle, C. S., Calman, K. C., Packard, C. J., & Shepherd, J. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90189-9 · Cited by 52
Singh, A. T. K., Evens, A. M., Anderson, R. J., Beckstead, J. A., Natesan, S., Sassano, A., Bhalla, S., Yang, S., Platanias, L. C., Forte, T. M., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08209.x · Cited by 48
Imachi, H., Murao, K., Sayo, Y., Hosokawa, H., Sato, M., Niimi, M., Kobayashi, S., Miyauchi, A., Ishida, T., & Takahara, J. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.27 · Cited by 47
Corbin, I. R., Ng, K. K., Ding, L., Jurisicova, A., & Zheng, G. (2012) · Nanomedicine · doi:10.2217/nnm.12.137 · Cited by 45
Zhang, W., Xiao, Y., Liu, J., Wu, Z., Gu, X. Q., Xu, Y., & Lu, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.039 · Cited by 41
Lin, Q., Chen, J., Jin, H., Ng, K. K., Yang, M., Cao, W., Ding, L., Zhang, Z., & Zheng, G. (2012) · Nanomedicine · doi:10.2217/nnm.12.73 · Cited by 40
Fischer, N. O., Infante, E., Ishikawa, T., Blanchette, C., Bourne, N., Hoeprich, P. D., & Mason, P. W. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100083d · Cited by 39
Weilhammer, D. R., Blanchette, C., Fischer, N. O., Alam, S., Loots, G. G., Corzett, M., Thomas, C. B., Lychak, C., Dunkle, A. D., Ruitenberg, J. J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.038 · Cited by 38
A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells
Smith, J. S., Xu, Z., & Byrnes, A. P. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.08.009 · Cited by 38
Hirata, K., Maruyama, T., Watanabe, H., Maeda, H., Nakajou, K., Iwao, Y., Ishima, Y., Katsumi, H., Hashida, M., & Otagiri, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.010 · Cited by 37
The Receptor Model for Transport of Cholesterol in Plasmaa
Brown, M. S., & Goldstein, J. L. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb11856.x · Cited by 34
Zhang, X., & Chen, B. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.05.023 · Cited by 34
SERUM LIPOPROTEINS AND THE EVALUATION OF ATHEROSCLEROSIS
Gofman, J. W. (1956) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1956.tb36833.x · Cited by 34
Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells
Feng, M., Cai, Q.-S., Shi, X., Huang, H. Y., Zhou, P., & Guo, X. D. (2008) · Journal of drug targeting · doi:10.1080/10611860802200938 · Cited by 34
Novel therapeutic strategies based on toll-like receptor signaling
Lawton, J. A., & Ghosh, P. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00077-2 · Cited by 32
Emerging therapeutic strategies to enhance HDL function
Redondo, S., Martínez‐González, J., Urraca, C., & Tejerina, T. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-175 · Cited by 32
Subramanian, C., Kuai, R., Zhu, Q., White, P., Moon, J. J., Schwendeman, A. A., & Cohen, M. S. (2015) · Surgery · doi:10.1016/j.surg.2015.08.023 · Cited by 31
Self-citationDeng, Q., Bourgine, M., Zhang, X., Cumont, M., Zhu, R., Lone, Y. C., & Michel, M. (2009) · Hepatology · doi:10.1002/hep.23150 · Cited by 30
Kempen, H. J. M., Schranz, D. B., Asztalos, B. F., Otvos, J. D., Jeyarajah, E. J., Drazul‐Schrader, D., Collins, H. L., Adelman, S. J., & Wijngaard, P. L. J. (2014) · Journal of Lipids · doi:10.1155/2014/923903 · Cited by 27
de Vrueh, R. L. A., Rump, E. T., van de Bilt, E., van Veghel, R., Balzarini, J. M., Biessen, E. A. L., van Berkel, T. J. C., & Bijsterbosch, M. K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.477-483.2000 · Cited by 23
Lipid-Based Nanoparticles for Vaccine Applications
Kuai, R., Ochyl, L. J., Schwendeman, A. A., & Moon, J. J. (2015) · Biosystems & biorobotics · doi:10.1007/978-3-319-21813-7_8 · Cited by 10
Self-citation
Cited by
Designer vaccine nanodiscs for personalized cancer immunotherapy
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017) · Nature Materials · doi:10.1038/nmat4822 · Cited by 1,056
Self-citationLipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 626
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Kuai, R., Yuan, W., Son, S., Nam, J., Xu, Y., Fan, Y., Schwendeman, A., & Moon, J. J. (2018) · Science Advances · doi:10.1126/sciadv.aao1736 · Cited by 352
Self-citationEngineering patient-specific cancer immunotherapies
Scheetz, L., Park, K. S., Li, Q., Lowenstein, P. R., Castro, M. G., Schwendeman, A., & Moon, J. J. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0436-x · Cited by 208
Self-citationSugasini, D., Thomas, R., Yalagala, P. C. R., Tai, L. M., & Subbaiah, P. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-11766-0 · Cited by 201
Metadata
- Authors
- Kuai, R., Li, D., Chen, Y. E., Moon, J. J., & Schwendeman, A.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-02-25
- Volume
- 10
- Issue
- 3
- Pages
- 3015-3041
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2505614715
- Cited by
- 338
- References
- 197
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.